Literature DB >> 15193145

Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58).

Rachel Tréhin1, Hanne M Nielsen, Heinz-Georg Jahnke, Ulrike Krauss, Annette G Beck-Sickinger, Hans P Merkle.   

Abstract

We assessed the metabolic degradation kinetics and cleavage patterns of some selected CPP (cell-penetrating peptides) after incubation with confluent epithelial models. Synthesis of N-terminal CF [5(6)-carboxyfluorescein]-labelled CPP, namely hCT (human calcitonin)-derived sequences, Tat(47-57) and penetratin(43-58), was through Fmoc (fluoren-9-ylmethoxycarbonyl) chemistry. Metabolic degradation kinetics of the tested CPP in contact with three cell-cultured epithelial models, MDCK (Madin-Darby canine kidney), Calu-3 and TR146, was evaluated by reversed-phase HPLC. Identification of the resulting metabolites of CF-hCT(9-32) was through reversed-phase HPLC fractionation and peak allocation by MALDI-TOF-MS (matrix-assisted laser-desorption ionization-time-of-flight mass spectrometry) or direct MALDI-TOF-MS of incubates. Levels of proteolytic activity varied highly between the investigated epithelial models and the CPP. The Calu-3 model exhibited the highest proteolytic activity. The patterns of metabolic cleavage of hCT(9-32) were similar in all three models. Initial cleavage of this peptide occurred at the N-terminal domain, possibly by endopeptidase activity yielding both the N- and the C-terminal counterparts. Further metabolic degradation was by aminopeptidase, endopeptidase and/or carboxypeptidase activities. In conclusion, when in contact with epithelial models, the studied CPP were subject to efficient metabolism, a prerequisite of cargo release on the one hand, but with potential for premature cleavage and loss of the cargo as well on the other. The results, particularly on hCT(9-32), may be used as a template to suggest structural modifications towards improved CPP performance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193145      PMCID: PMC1133970          DOI: 10.1042/BJ20040238

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Protein transduction: unrestricted delivery into all cells?

Authors:  S R Schwarze; K A Hruska; S F Dowdy
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

2.  Deletion analogues of transportan.

Authors:  U Soomets; M Lindgren; X Gallet; M Hällbrink; A Elmquist; L Balaspiri; M Zorko; M Pooga; R Brasseur; U Langel
Journal:  Biochim Biophys Acta       Date:  2000-07-31

Review 3.  Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3.

Authors:  Bogdan I Florea; Maria L Cassara; Hans E Junginger; Gerrit Borchard
Journal:  J Control Release       Date:  2003-02-21       Impact factor: 9.776

4.  Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas.

Authors:  W E Finkbeiner; S D Carrier; C E Teresi
Journal:  Am J Respir Cell Mol Biol       Date:  1993-11       Impact factor: 6.914

5.  Identification of two strains of MDCK cells which resemble separate nephron tubule segments.

Authors:  J C Richardson; V Scalera; N L Simmons
Journal:  Biochim Biophys Acta       Date:  1981-02-18

6.  Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa.

Authors:  S Lang; P Langguth; R Oschmann; B Traving; H P Merkle
Journal:  J Pharm Pharmacol       Date:  1996-11       Impact factor: 3.765

7.  From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.

Authors:  B Rist; M Entzeroth; A G Beck-Sickinger
Journal:  J Med Chem       Date:  1998-01-01       Impact factor: 7.446

8.  Solution structure of human calcitonin in membrane-mimetic environment: the role of the amphipathic helix.

Authors:  A Motta; G Andreotti; P Amodeo; G Strazzullo; M A Castiglione Morelli
Journal:  Proteins       Date:  1998-08-15

9.  A fast and inexpensive method for N-terminal fluorescein-labeling of peptides.

Authors:  P J Weber; J E Bader; G Folkers; A G Beck-Sickinger
Journal:  Bioorg Med Chem Lett       Date:  1998-03-17       Impact factor: 2.823

10.  Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion.

Authors:  B Q Shen; W E Finkbeiner; J J Wine; R J Mrsny; J H Widdicombe
Journal:  Am J Physiol       Date:  1994-05
View more
  18 in total

Review 1.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

2.  A peptide for transcellular cargo delivery: Structure-function relationship and mechanism of action.

Authors:  Alexander Komin; Maxim I Bogorad; Ran Lin; Honggang Cui; Peter C Searson; Kalina Hristova
Journal:  J Control Release       Date:  2020-05-28       Impact factor: 9.776

3.  Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures.

Authors:  Christina Foerg; Kathrin M Weller; Helene Rechsteiner; Hanne M Nielsen; Jimena Fernández-Carneado; René Brunisholz; Ernest Giralt; Hans P Merkle
Journal:  AAPS J       Date:  2008-06-28       Impact factor: 4.009

4.  Cell-penetrating peptides as delivery vehicles for a protein-targeted terbium complex.

Authors:  Shabnam Mohandessi; Megha Rajendran; Darren Magda; Lawrence W Miller
Journal:  Chemistry       Date:  2012-07-17       Impact factor: 5.236

5.  Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides.

Authors:  Michael E Herbig; Kathrin Weller; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle; Oliver Zerbe
Journal:  Biophys J       Date:  2005-09-23       Impact factor: 4.033

Review 6.  Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.

Authors:  Mie Kristensen; Hanne Mørck Nielsen
Journal:  Tissue Barriers       Date:  2016-04-18

7.  PKA-type I selective constrained peptide disruptors of AKAP complexes.

Authors:  Yuxiao Wang; Tienhuei G Ho; Eugen Franz; Jennifer S Hermann; F Donelson Smith; Heidi Hehnly; Jessica L Esseltine; Laura E Hanold; Mandi M Murph; Daniela Bertinetti; John D Scott; Friedrich W Herberg; Eileen J Kennedy
Journal:  ACS Chem Biol       Date:  2015-03-25       Impact factor: 5.100

8.  TAT peptide and its conjugates: proteolytic stability.

Authors:  Jacob Grunwald; Tomas Rejtar; Rupa Sawant; Zhouxi Wang; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2009-07-14       Impact factor: 4.774

9.  Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.

Authors:  Leena N Patel; Jeffrey Wang; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

10.  Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.

Authors:  Anjali Apte; Erez Koren; Alexander Koshkaryev; Vladimir P Torchilin
Journal:  Cancer Biol Ther       Date:  2013-10-21       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.